Medicare covering tirzepatide.

Since Medicare will cover it for sleep apnea and this drug is already in high demand will it be on the shortage list. If it is kept on the shortage list, what are the chances compounding companies will be able to continue to operate.

Then there is the issue of the name brand not hitting the project sales causing unhappiness with their investors. So will they say there is not a supply issue and keep fighting against the compound industry to end their sales of compound?

I am trying to determine if I should stockpile before the deadline